Land: Storbritannia
Språk: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Sodium picosulfate; Citric acid monohydrate; Magnesium oxide light
Casen Recordati S.L.
A06AB58
Sodium picosulfate; Citric acid monohydrate; Magnesium oxide light
10mg ; 12gram ; 3.5gram
Oral powder
Oral
No Controlled Drug Status
Never Valid To Prescribe As A VMP
BNF: 01060500
PACKAGE LEAFLET: INFORMATION FOR THE USER CITRAFLEET, POWDER FOR ORAL SOLUTION IN SACHET SODIUM PICOSULFATE, LIGHT MAGNESIUM OXIDE, CITRIC ACID ANHYDROUS. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. However, you still need to take CitraFleet carefully to get the best results from it. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What CitraFleet is and what it is used for 2. What you need to know before you take CitraFleet 3. How to take CitraFleet 4. Possible side effects 5. How to store CitraFleet 6. Contents of the pack and other information 1. WHAT CITRAFLEET IS AND WHAT IT IS USED FOR You are taking CitraFleet to clean your bowels (also known as intestines and colon) before having any diagnostic procedure that requires a clean bowel, for example a colonoscopy (procedure that looks inside your bowel using a long, flexible instrument that the doctor inserts through your anus) or x-ray examination. CitraFleet is a powder that smells and tastes of lemons. It contains two types of laxatives mixed in each sachet which, when dissolved in water and drunk, wash-out and clean the bowels. It is important to have an empty, clean bowel so that your doctor or surgeon can see it clearly. Citrafleet is indicated in adults (including the elderly) aged 18 years and over. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CITRAFLEET DO NOT TAKE CITRAFLEET IF YOU: - are ALLERGIC to sodium picosulfate, magnesium oxide, citric acid or any of the other ingredients of this medicine (listed in section 6). - have CONGESTIVE HEART FAILURE (your heart is unable to properly pump blood round the body) - have a condition cal Les hele dokumentet
OBJECT 1 CITRAFLEET POWDER FOR ORAL SOLUTION Summary of Product Characteristics Updated 18-Aug-2017 | Casen Recordati S.L. 1. Name of the medicinal product CitraFleet, Powder for oral solution in sachet 2. Qualitative and quantitative composition Each sachet (15.08 g) contains the following active ingredients: Sodium picosulfate 10.0 mg Light magnesium oxide 3.5 g Citric acid anhydrous 10.97 g Excipient(s) with known effect: each sachet also contains 5 mmol (or 195 mg) potassium (see section 4.4) For the full list of excipients, see section 6.1. 3. Pharmaceutical form Powder for oral solution, in sachet. White crystalline powder with a lemon flavour. 4. Clinical particulars 4.1 Therapeutic indications For bowel cleansing prior to any diagnostic procedures requiring a clean bowel e.g. colonoscopy or x-ray examination. CitraFleet is indicated in adults (including the elderly) aged 18 years and over. 4.2 Posology and method of administration Posology _Adults (including the elderly) aged 18 years and over_ The treatment can be administered in one of the following ways: • Usually, one sachet on the evening prior to the procedure and the second sachet in the morning of the day of the procedure. • Alternatively, both sachets on the afternoon and evening prior to the procedure. This schedule is more suitable when the procedure is early in the morning. The time elapsed between the two sachets should be at least 5 hours. Method of administration _Route of administration: Oral use._ For instructions on reconstitution of the medicinal product before administration, see section 6.6 A low residue diet or only clear liquids on the day before the procedure is recommended. No solid food should be taken from the start of the course of treatment until after the procedure. Because the osmolarity of the product needs to be maintained in order to obtain the desired effect, each sachet should be reconstituted in a cup of water. Do not further dilute the product by drinking liquid immediately after the intake of each sachet. After a Les hele dokumentet